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Clostridium difﬁcile colitis and cytomegalovirus colitis coinfection has been documented in immuno-
compromised patients. However, this kind of coinfection has rarely been reported in immunocompetent
patients. We present a 90-year-old, critically ill, immunocompetent patient, who had a C. difﬁcile and
cytomegalovirus colitis coinfection. Although the common risk factors of both types of colitis are well
known, clinical physicians still need to be alert to this coinfection because severe complications of CMV
colitis have been reported previously. Physicians should be more aggressive in the management of
elderly immunocompetent patients with refractory symptoms of colitis.
Copyright © 2015, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Immunosuppression is a risk factor for both Clostridium difﬁcile
colitis and cytomegalovirus (CMV) infection1,2. Immunocompetent
patients are also at risk of developing these diseases, especially
those who are elderly or critically ill1,2. CMV colitis superimposed
on C. difﬁcile colitis in immunocompromised hosts such as solid
organ transplant recipients has been reported3. However,
C. difﬁcile-CMV colitis coinfection, which was ﬁrst reported in 1992,
is rare in immunocompetent patients4. Herein, we report an elderly
immunocompetent patient with C. difﬁcile-CMV colitis coinfection.2. Case report
A 90-year-old male, who had a stroke 10 years ago and had been
under chronic bedridden status, lived in a nursing home facility. He
initially had pneumonia with respiratory failure and was admittedfﬁliations with or ﬁnancial
le future, any organization or
t with the subject matter or
disclosed (e.g., employment,
, expert testimony, grants, or
nt of Internal Medicine, Tai-
3, Taichung Port Road, Xitun
).
tric Emergency & Critical Care Meto an intensive care unit. He had been treated for pneumonia with
multiple courses of antibiotics for 2 weeks. However, bloody diar-
rhea and poor digestion developed and a computed tomography of
the abdomen showed thickening of the wall of the descending
colon. The result of an enzyme immunoassay was positive for stool
C. difﬁcile toxin. The patient was given oral metronidazole at
500 mg three times per day for 8 days, but the diarrhea was only
partially relieved. Sigmoidoscopy was performed and was
advanced to the distal descending colon, where multiple ulcers
with inﬂammatory changes were found (Fig. 1). Sigmoidoscopic
biopsy over the ulcerative areawas performed. Pathological ﬁnding
for CMV immunohistochemistry stain was positive with presenta-
tion of typical intranuclear inclusions (Fig. 2). We prescribed
intravenous ganciclovir at 5 mg/kg every 12 hours and kept the
treatment course for pseudomembranous colitis because of re-
fractory diarrhea. CMV quantitative blood polymerase chain reac-
tion (PCR) performed 4 days after initiation of treatment with
ganciclovir, revealed < 333 copies/mL. human immunodeﬁciency
virus serology test was nonreactive and antinuclear antibody titer
was insigniﬁcant. The patient was not exposed to any corticoste-
roids during this course of treatment. His symptoms of poor
digestion and diarrhea gradually improved 1 week later after
ganciclovir was added. When he ﬁnished the 2-week course of oral
vancomycin and intravenous ganciclovir, the symptoms of diarrhea
and digestion had improved greatly. However, the patient accepted
a tracheostomy because of difﬁculty in weaning from mechanical
ventilation. He was later transferred to a chronic respiratory care
ward for long-term care.dicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Erythematous colonic mucosa with focal ulcer and hemorrhage in the sigmoid
colon.
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Clostridium difﬁcile and Cytomegalovirus Colitis 1313. Discussion
Risk factors for C. difﬁcile colitis and CMV colitis, including
immunosuppression, older age, critically ill conditions, inﬂamma-
tory bowel disease, postsurgical state, and high disease severity,
have been mentioned in several studies1,2,5e7. The universal
symptoms of both types of colitis are diarrhea, fever, and abdominal
pain. Moreover, bloody diarrhea may be a bothersome symptom5,8.
Although C. difﬁcile colitis is generally not difﬁcult to treat, drug
resistant pathogens may cause severe complications, especially
when there are widespread regional outbreaks associated with a
previously uncommon hypervirulent strain of C. difﬁcile.1
Alkhatib et al9 reported an immunocompetent case of resistant
C. difﬁcile colitis and CMV colitis coinfection and they ﬁrst proposed
the term “triple C disease”. A case of a young male patient was
documented in Singapore10. Another report presented a 78-year-
old woman who suffered from the coinfection with recovery to
baseline health status after serial antibiotics, antiviral treatment,Fig. 2. Hematoxylin and eosin stain showing a typical intranuclear inclusion body. Ta
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P.-H. Chen et al.132and total colectomy11. CMV infection in immunocompetent pa-
tients was previously thought to be rare and these patients were
considered to have a benign course. In the literature, C. difﬁcile
colitis and CMV colitis coinfection in immunocompromised pa-
tients has been well documented3, but cases of immunocompetent
patients are very rare. To our knowledge, our case is the oldest one
among the limitedly number of immunocompetent cases with co-
infection reported in the literature (Table 1). In addition to the
aforementioned young patient, another patient reported in the
literature was 81 years old. It is well known that this coinfection is
more common in immunocompromised patients. However, old age
might be the key reason to explain why this coinfection occurs in
immunocompetent patients.
Previous case reports did not mention the delay duration
(Table 1), but we delayed treatment of the CMV pathogen for 14
days. It seems that the diagnosis of CMV colitis is usually delayed
after C. difﬁcile colitis has been diagnosed. This is probably because
clinical physicians are less alert to CMV infection in immunocom-
petent patients. The young immunocompetent patient in Singapore
died of multiple organ failure caused by multiple resistant patho-
gens10. Early diagnosis of the superimposed CMV infection might
shorten the hospital course and lessen the possibility of a poten-
tially lethal nosocomial infection.
Although the CMV quantitative blood PCR of our patient was not
high, the data might be inﬂuenced by ganciclovir treatment
because the decline of the viral load in the blood after intravenous
ganciclovir therapy may be quick12. Moreover, detection of CMV by
PCR alone is insufﬁcient for the diagnosis of CMV gastrointestinal
disease13. Accordingly, the utility of a serology test is limited in
immunocompetent patients because of the requirement for paired
serum samples and longer detectable period of CMV-speciﬁc
immunoglobulin M autoantibodies after the onset of symptoms14.
Clinical physicians began to pay attention to less common
problems such as CMV infection when clinical symptoms of
C. difﬁcile colitis did not improve after treatment. Although previ-
ous studies could not prove that antiviral treatment is effective in
immunocompetent patients with severe CMV infections15, timely
treatment might be helpful in the improvement of symptoms and
outcome, as shown in a previously published case in 20099 and the
current case. It became clear that prolonged hospital stays or higher
risks of severe life-threatening complications of CMV infection in
immunocompetent patients are not as rare as previously thought15.
Previous studies15,16 implied a cytokine cascade may increase
the potential to reactivate the latent CMV infection in patients with
inﬂammatory bowel disease. As for the reason of C. difﬁcile colitispreceding CMV colitis, the cytokines induced by C. difﬁcile colitis
may play an important role even though the interaction is not yet
clear. This may explain why CMV infection developed after
C. difﬁcile colitis in our case.
In conclusion, clinical physicians should be alert to the possi-
bility of CMV coinfection, especially when an elderly and critically
ill patient has refractory or recurrent symptoms of C. difﬁcile colitis.
Early endoscopic study might be helpful to differentiate disease or
to evaluate disease severity. Prompt antiviral treatment after
diagnosis might play a role in improvement of symptoms and
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